Wednesday, July 8, 2026

Drug profile · INN

carbon dioxide

carbon dioxide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 2
Pipeline programs 1
News articles 0
Drug details — carbon dioxide
US status
approved
Class
Route
INHALATION
Patents
2
Programs
1
Data quality
0.84

Quick answer

carbon dioxide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

Key facts

INN carbon dioxide
Brand CARBON DIOXIDE, USP
Route INHALATION
Formulation GAS

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Nasal Carbon Dioxide Phase 2 · United Therapeutics Europe · Migraine

Related patents

  1. US 12232492

    Disinfection of bacteriophages products using supercritical carbon dioxide

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11790574

    System and method for carbon dioxide angiographic roadmap imaging

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is carbon dioxide?

carbon dioxide (CARBON DIOXIDE, USP) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.

What is the brand name for carbon dioxide?

CARBON DIOXIDE, USP is a marketed brand name for carbon dioxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of carbon dioxide?

carbon dioxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.